SEC Form 4 · accession 0001387131-15-001038
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Martin Carroll
Director
Period of report
Mar 25, 2015
Accepted (ET)
Mar 26, 2015 · 9:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock option | $5.92 | Mar 25, 2015 | A | 100,000 | A | Dec 31, 2015 | Mar 24, 2025 | Common Stock | 100,000 | 100,000 | D |